Codexis Stock Price and Value Analysis

Codexis (NasdaqGS:CDXS) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Codexis to reach your target.

Target type

CDXS Free Cash Flow Trend

Free Cash Flow trendline for CDXS
Free Cash Flow trendline for Codexis

Hmm, we can't give any reliable projection for Codexis's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the CDXS Numbers

CDXS Price
(Codexis stock price per share)
$1.44
[?] PE Ratio versus Sector 100% lower than other Basic Materials stocks
[?] PE Ratio versus Industry 100% lower than other Chemicals stocks
[?] Cash Yield -15.41%
[?] Free Cash Flow Jitter 28%

Insider Activity Summary

No open-market insider buys or sells are recorded in the six months to 2026-11-12.

The six months before that had 0 buys and 6 sales.

Recent Insider Activity

Open-market buys and sells reported by Codexis's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2025-12-01 Opaleye Management Inc. Sell 245,000 $1.67
2025-12-01 Opaleye Management Inc. Sell 8,533 $1.67
2025-11-28 Opaleye Management Inc. Sell 2,490 $1.75
2025-11-28 Opaleye Management Inc. Sell 105,000 $1.75
2025-11-26 Opaleye Management Inc. Sell 148,318 $1.74
2025-11-26 Opaleye Management Inc. Sell 5,000 $1.74
2025-11-12 Opaleye Management Inc. Sell 27,459 $1.94
2025-11-12 Opaleye Management Inc. Sell 165,000 $1.96
2025-11-12 Opaleye Management Inc. Sell 890,000 $1.94
2025-11-11 Opaleye Management Inc. Sell 535,000 $1.80

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,724,621 shares shorted. With 82,348,335 shares available for purchase and an average trading volume over the past 10 trading days of 817,530, it would take at least 4.6 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1200375 -19.5
2010 1200375 -25.2
2011 1200375 -10.0
2012 1200375 -19.7
2013 1200375 -29.5
2014 1200375 -4.1
2015 1200375 -3.7
2016 1200375 -3.2
2017 1200375 -9.7
2018 1200375 -15.3
2019 1200375 -14.5
2020 1200375 -18.9
2021 1200375 -19.3
2022 1200375 4.8
2023 1200375 -59.4
2024 1200375 -56.3
2025 1200375 -26.4

Download the yearly data as CSV.

Price Versus Our Estimated Value

Of the 17 fiscal years we can see for Codexis under its current filer, 1 show positive free cash flow.

Year-to-year variability in free cash flow is uneven, measured at 28%.

We do not estimate a fair value for Codexis while its free cash flow growth is not positive, so there is no value comparison here.

Dividends are not in our data for Codexis.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

Its trailing P/E ratio is 100% below the average for stocks in the Basic Materials sector.

Its trailing P/E ratio is 100% below the average for stocks in the Chemicals industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1200375.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow was negative in 16 of the 17 years we have.
  • We have no value estimate for this stock, so no price comparison is made.
  • This page's data was last updated on 2026-09-10. Prices and filings may have changed since.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in CDXS

Does Codexis have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: CDXS

This example shows how we apply the Trendshare checklist to CDXS: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 1.44
    • Market cap: $158M
    • EPS: -0.33
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: -15.4%
    • Date checked: Sep 10, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.